Medpace Holdings, Inc.: Amended Second Amended and Restated Bylaws to remove limitation on stockholders calling special meetings, allow owners of 25% voting power to call a special meeting, and implement conforming changes.
“the Board approved amendments to the Second Amended and Restated Bylaws of the Company to remove the limitation on stockholders calling special meetings of stockholders, to provide one or more stockholders as a group owning at least 25% of the voting power of the Company’s outstanding shares the right to call a special meeting, and to implement other conforming and clarifying changes”
Governance Changes
Medpace Holdings, Inc.: Removed supermajority voting requirements and limitation on stockholders calling special meetings via amendments to the Restated Certificate of Incorporation (effective 2026-05-18).
“(i) to remove supermajority voting requirements and (ii) to remove the limitation on stockholders calling special meetings of stockholders. The Amendments became effective immediately upon the filing of a certificate of amendment setting forth the same with the Secretary of State of the State of Delaware on May 18, 2026.”
Earnings Releases
Medpace Holdings, Inc. reported financial results for the three months ended March 31, 2026.
“Medpace Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026. The full text of the press release was posted on the Company’s internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference.”
Dani S. Zander was elected as Director at Medpace Holdings, Inc..
“The Board of the Company following a recommendation from the independent directors of the Board, unanimously approved that Dr. Dani S. Zander be elected to fill the Class III director vacancy on the Board of the Company, effective July 1, 2024”
Ashley M. Keating resigned as Director at Medpace Holdings, Inc..
“On June 28, 2024, Ashley M. Keating, a member of the Board of Directors (the “Board”) of Medpace Holdings, Inc. (the “Company”) notified the Company of her resignation, effective as of June 30, 2024.”
Earnings Releases
Medpace Holdings, Inc. reported financial results for the three months ended March 31, 2024.
“On April 22, 2024, Medpace Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2024.”
Material Agreements
Medpace Holdings, Inc. amended Amendment No. 6 to Loan Documents with PNC Bank, National Association valued at up to $10 million (effective 2024-03-28).
“Medpace Holdings, Inc., a Delaware corporation (the "Company"), through its wholly owned subsidiaries, Medpace, Inc., as borrower, and Medpace IntermediateCo, Inc., as guarantor, entered into Amendment No. 6 to Loan Documents (“Amendment No. 6”) with PNC Bank, National Association”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.